In cardiovascular care, we envision a world with no preventable CV deaths and are using cutting-edge science and technology in our mission to ensure no heart is lost too soon.
In kidney disease, we are building on our groundbreaking work that began in transplant, with an expanding portfolio of medicines that address the underlying causes of disease, starting with kidney conditions that have significant unmet need.
